Voloridge Investment Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.77M | Buy |
|
|||||
|
2025
Q2 | $3.24M | Sell |
|
|||||
|
2025
Q1 | $13.2M | Buy |
|
|||||
|
2024
Q4 | $2.19M | Buy |
|
|||||
|
2024
Q3 | $763K | Sell |
|
|||||
|
2024
Q2 | $1.85M | Sell |
|
|||||
|
2024
Q1 | $5.51M | Buy |
|
|||||
|
2023
Q4 | $2.51M | Buy |
|
|||||
|
2023
Q3 | $1.06M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $4.53M | Buy |
|
|||||
|
2021
Q2 | $2.08M | Buy |
|
|||||
|
2021
Q1 | $267K | Sell |
|
|||||
|
2020
Q4 | $6.8M | Buy |
|
|||||
|
2020
Q3 | $6.64M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $340K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $567K | Sell |
|
|||||
|
2018
Q4 | $1.17M | Sell |
|
|||||
|
2018
Q3 | $2.76M | Buy |
|